Canaccord raised the firm’s price target on iRhythm (IRTC) to $212 from $193 and keeps a Buy rating on the shares. The firm said they had a stellar quarter, highlighted by strength across both product lines (Monitor and AT), strong FCF, and increased guidance with revenue and adj. EBITDA guidance raised more than the beat.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRTC:
- Irhythm Technologies: Strong Q3 Performance and Positive Outlook Justify Buy Rating
- Irhythm Technologies: Strong Performance and Promising Growth Potential Justify Buy Rating
- iRhythm Technologies: Strong Growth and Strategic Initiatives Justify Buy Rating
- iRhythm Technologies Reports Strong Q3 2025 Growth
- Closing Bell Movers: Amazon soars to all-time highs on earnings